SAN DIEGO, Jan. 6, 2011 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced that the Company will be speaking at the JP Morgan Healthcare Conference. The details are as follows:
JP Morgan Healthcare Conference | |
Date: January 12, 2011 | |
Time: 9:30AM-10:00AM Pacific Time | |
Location: Westin St. Francis Hotel, San Francisco, California | |
Speaker: Mike Narachi, Chief Executive Officer | |
About Orexigen Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Further information about the Company can be found at http://www.orexigen.com.
SOURCE Orexigen Therapeutics, Inc.
